Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models

Novartis Foundation Symposium

Volumn 280, Issue , 2007, Pages 165-175

  Ryter, Stefan W ^a   Choi, Augustine M K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBON MONOXIDE;

ANIMAL; DRUG EFFECT; HUMAN; LUNG DISEASE; OXIDATIVE STRESS; PATHOLOGY; REPERFUSION INJURY; REVIEW; SEPSIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARBON MONOXIDE; HUMANS; LUNG DISEASES; OXIDATIVE STRESS; REPERFUSION INJURY; SEPSIS; SIGNAL TRANSDUCTION;

EID: 34247143677     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (29)

1. Amersi F, Shen XD, Anselmo D et al 2002 Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 35:815-823
2. Bilban M, Bach FH, Otterbein SL et al 2006 Carbon monoxide orchestrates a protective response through PPARgamma. Immunity 24:601-610
3. Fujita T, Toda K, Karimova A et al 2001 Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7:598-604
4. Furchgott RF, Jothianandan D 1991 Endothelium-dependent and independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28:52-61
5. Kim HP, Wang X, Galbiati F, Ryter SW, Choi AMK 2004 Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J 18:1080-1089
6. Kim HP, Wang X, Zhang J et al 2005a Heat shock protein 70 mediates the cytoprotective effect of carbon monoxide: involvement of p38B MAPK and heat shock factor-1. J Immunol 175:2622-2629
7. Kim HP, Wang X, Nakao A et al 2005b Caveolin-1 expression by means of p38β mitogen activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc Natl Acad Sci 102:11319-11324
8. Kim HP, Ryter SW, Choi AM 2006 CO as a cellular signaling molecule. Ann Rev Pharm Tox 46:411-449
9. Morita T, Perrella MA, Lee ME, Kourembanas S 1995 Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92:1475-1479
10. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S 1997 Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272:32804-323809
11. Morse D, Pischke SE, Zhou Z et al 2003 Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 278:36993-36998
12. Nakahira K, Kim HP, Geng XH et al 2006 Carbon monoxide differentially inhibits TLRs signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 203:2377-2389
13. Nakao A, Kimizuka K, Stolz DB et al 2003 Protective effect of carbon monoxide inhalation for cold-preserved small intestinal grafts. Surgery 134:285-292
14. Nakao A, Neto JS, Kanno S et al 2005 Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 5:282-291
15. Otterbein LE, Mantell LL, Choi AM 1999 Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 276:L688-L694
16. Otterbein LE, Bach FH, Alam J et al 2000 Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422-428
17. Otterbein LE, Otterbein SL, Ifedigbo E et al 2003a MKK3 mitogen activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant induced lung injury. Am J Pathol 163:2555-2563
18. Otterbein LE, Zuckerbraun BS, Haga M et al 2003b Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9:183-190
19. Ryter SW, Tyrrell RM 2000 The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med 28:289-309
20. Ryter SW, Otterbein L 2004 Carbon monoxide in biology and medicine. Bioessays 26:270-280
21. Ryter SW, Morse D, Choi AMK 2004 Carbon monoxide: to boldly go where NO has gone before. Sci STKE 230:re6
22. Ryter SW, Alam J, Choi AM 2006 Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583-650
23. Sarady JK, Zuckerbraun BS, Bilban M et al 2004 Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J 18:854-856
24. Slebos DJ, Ryter S, Choi AM 2003 Heme oxygenase-1 and carbon monoxide in pulmonary medicine. Respir Res 4:7
25. Tenhunen R, Marver HS, Schmid R 1969 Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 244:6388-6394
26. Vile GF, Tyrrell RM 1993 Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin. J Biol Chem 268:14678-14681
27. Von Berg R 1999 Toxicology update. Carbon monoxide. J Appl Toxicol 19:379-386
28. Zhang X, Shan P, Otterbein LE et al 2003 Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase and involves caspase-3. J Biol Chem 278:1248-1258
29. Zuckerbraun BS, Billiar TR, Otterbein SL et al 2003 Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase-1. J Exp Med 198:1-11